News
Michael Phelps is no longer going to stay quiet about the state of swimming in the United States. The legendary Olympian will ...
According to AMD, the entry-level gaming card can achieve triple-digit frame rates at native 1080p Ultra settings in titles ...
Novo Nordisk remains a strong buy despite share price dip, thanks to its robust drug pipeline, massive market potential, and ...
At least 26 patients have filed lawsuits in Marion County against Eli Lilly and Co. over its marketing of GLP-1 drugs ...
1h
MarketBeat on MSNNovo Nordisk Stock Sinks-But Is a Bottom Finally In?Novo Nordisk A/V (NYSE: NVO) stock is testing the patience of buy-and-hold investors. Over the last five years, NVO stock is ...
Novo Nordisk underestimated the impact of competition from personalized compounded drugs when providing sales estimates for ...
Lilly, 21, looked radiant in a fitted black top paired with mom jeans and white trainers as she shared a snap cuddling Lee - ...
President Donald Trump’s firing Friday of BLS Commissioner Erika McEntarfer — a Biden appointee who’d been confirmed with overwhelming bipartisan support — pierced BLS’s reputation and created ...
1h
Zacks Investment Research on MSNPfizer (PFE) Surpasses Q2 Earnings and Revenue EstimatesPfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are ...
Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
Choice of therapy to control high blood sugar may affect survival among older adults with cancer and type 2 diabetes, according to study results.Those who used GLP-1 receptor agonists exhibited ...
Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track Preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results